Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Filings indexed 1,263 across all filing types
Latest filing 2023-07-12 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about the lost share certificates and the shareholders involved. There is no financial data, report, or presentation included. The document is an official notification related to share certificates but does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is a regulatory announcement informing the exchanges about a specific event concerning share certificates. Given the nature and content, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories. The document length is short and does not indicate it is a report publication announcement or a certification. Therefore, the classification is RNS with high confidence.
2023-07-12 English
Pursuant to Regulation 39(3) and other applicable regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and related disclosures. The content is an official notification about a shareholder's lost share certificates and does not contain financial data, management discussion, voting results, or any report publication. It is a regulatory announcement related to shareholding records but does not fit into categories like Major Shareholding Notification (MRQ) since it is about lost certificates, not ownership changes. It is not a report or a meeting material. Therefore, the best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2023-07-12 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates, referencing SEBI regulations. It is an announcement related to shareholding details but does not contain financial data, management discussion, or report content. The document is short (1480 characters) and serves as a regulatory notification about share certificate loss, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like Major Shareholding Notification (MRQ) or Director's Dealing (DIRS).
2023-07-06 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and related disclosures. The content is an announcement about a shareholder's lost share certificates and does not contain financial data, management discussion, or report publication. It is not a report or financial statement but a regulatory disclosure related to shareholding records. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-07-06 English
Further to our intimation dated May 30, 2023, we wish to inform that the Record Date for determining the entitlement of the shareholders for the payment of the Dividend for the financial ....
Notice of Dividend Amount Classification · 100% confidence The document is a short notice addressed to stock exchanges regarding the record date for the payment of a final dividend for the financial year 2022-23. It specifies the record date and the expected payment date of the dividend. There is no detailed financial data, analysis, or report content. The document is an announcement related to dividend payment details, fitting the category of Notice of Dividend Amount (DIV). The document length is short (1066 characters), consistent with a dividend notice rather than a full report.
2023-07-03 English
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and related disclosures. The content is an announcement about a specific event concerning share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or meeting materials. This type of announcement fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2023-07-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.